Paloma Health, a healthtech start-up aiming to reduce wait times for access to NHS health services, has raised £2 million in a pre-seed round.

London-based life science investor Syncona today announced its interim results for the six months ending 30 September 2024.

Assura announced pre-tax profit of £77.1 million for the six months ending 30 September 2024, compared to a net loss of £17.8 million reported for the same period last year.